Drug Information

Drug General Information
Drug ID
D04YHZ
Former ID
DNC012036
Drug Name
3-Methoxycarbonyl-2-methyl-9H-beta-carbolin-2-ium
Drug Type
Small molecular drug
Indication Discovery agent Investigative [551248]
Formula
C14H13N2O2+
Canonical SMILES
C[N+]1=C(C=C2C3=CC=CC=C3NC2=C1)C(=O)OC
InChI
1S/C14H12N2O2/c1-16-8-12-10(7-13(16)14(17)18-2)9-5-3-4-6-11(9)15-12/h3-8H,1-2H3/p+1
InChIKey
UUMQQVGTICTWCW-UHFFFAOYSA-O
PubChem Compound ID
15630152
Target and Pathway
Target(s) Gamma-aminobutyric acid receptor subunit alpha-1 Target Info Inhibitor [551248]
Gamma-aminobutyric acid receptor Target Info Inhibitor [551248]
KEGG Pathway Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
GABAergic synapse
Morphine addiction
Nicotine addiction
Reactome Ligand-gated ion channel transport
GABA A receptor activation
WikiPathways SIDS Susceptibility Pathways
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
Iron uptake and transport
References
Ref 551248N-2 methylated quaternary derivatives of beta-carboline-3-carboxylates inhibit acetylcholinesterase in vitroO, Bioorg. Med. Chem. Lett. 3(12):2831-2836 (1993).
Ref 551248N-2 methylated quaternary derivatives of beta-carboline-3-carboxylates inhibit acetylcholinesterase in vitroO, Bioorg. Med. Chem. Lett. 3(12):2831-2836 (1993).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.